{"name":"LG Chem","slug":"lg-chem","ticker":"","exchange":"","domain":"lgchem.com","description":"LG Chem Ltd., often referred to as LG Chemical, is the largest Korean chemical company and is headquartered in Seoul, South Korea. It was the 9th largest chemical company in the world by sales in 2021. It was first established as the Lucky Chemical Industrial Corporation, which manufactured cosmetics. It is now solely a business-to-business company.","hq":"Seoul","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2003-01-01","label":"Factive first approved","drug":"Factive","drugSlug":"gemifloxacin","type":"approval","sentiment":"positive"},{"date":"2003-01-01","label":"Factive first approved","drug":"Factive","drugSlug":"gemifloxacin-mesylate","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"oncology","drugs":[{"name":"LBVE","genericName":"LBVE","slug":"lbve","indication":"Other","status":"phase_2"},{"name":"Dapagliflozin 10mg","genericName":"Dapagliflozin 10mg","slug":"dapagliflozin-10mg","indication":"Other","status":"marketed"},{"name":"Eupolio","genericName":"Eupolio","slug":"eupolio","indication":"Other","status":"phase_3"},{"name":"Fang Le Shu (Follitrope)","genericName":"Fang Le Shu (Follitrope)","slug":"fang-le-shu-follitrope","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"marketed"},{"name":"Guo Na Fen (Gonal-F)","genericName":"Guo Na Fen (Gonal-F)","slug":"guo-na-fen-gonal-f","indication":"Infertility in women undergoing assisted reproductive technology (ART) procedures","status":"marketed"},{"name":"LB54640","genericName":"LB54640","slug":"lb54640","indication":"Other","status":"phase_2"},{"name":"LC350189 200 mg","genericName":"LC350189 200 mg","slug":"lc350189-200-mg","indication":"Other","status":"phase_1"},{"name":"LG00034053","genericName":"LG00034053","slug":"lg00034053","indication":"Other","status":"phase_1"},{"name":"Phase 1b: LB-LR1109 and Atezolizumab","genericName":"Phase 1b: LB-LR1109 and Atezolizumab","slug":"phase-1b-lb-lr1109-and-atezolizumab","indication":"Other","status":"phase_1"},{"name":"nonsteroidal anti-inflammatory drug","genericName":"nonsteroidal anti-inflammatory drug","slug":"nonsteroidal-anti-inflammatory-drug","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Eupenta Inj.","genericName":"Eupenta Inj.","slug":"eupenta-inj","indication":"Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment","status":"marketed"},{"name":"Factive","genericName":"GEMIFLOXACIN","slug":"gemifloxacin","indication":"Acute bacterial bronchitis","status":"marketed"},{"name":"Factive","genericName":"GEMIFLOXACIN MESYLATE","slug":"gemifloxacin-mesylate","indication":"Acute bacterial bronchitis","status":"marketed"}]}],"pipeline":[{"name":"LBVE","genericName":"LBVE","slug":"lbve","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Dapagliflozin 10mg","genericName":"Dapagliflozin 10mg","slug":"dapagliflozin-10mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Eupenta Inj.","genericName":"Eupenta Inj.","slug":"eupenta-inj","phase":"marketed","mechanism":"Eupenta is a pentamidine-based antiprotozoal agent that disrupts parasite DNA and mitochondrial function.","indications":["Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment","Leishmaniasis","Trypanosomiasis"],"catalyst":""},{"name":"Eupolio","genericName":"Eupolio","slug":"eupolio","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Factive","genericName":"GEMIFLOXACIN","slug":"gemifloxacin","phase":"marketed","mechanism":"Small molecule","indications":["Acute bacterial bronchitis","Acute exacerbation of chronic bronchitis","Bacterial pneumonia","Chlamydial pneumonia","Haemophilus influenzae pneumonia"],"catalyst":""},{"name":"Factive","genericName":"GEMIFLOXACIN MESYLATE","slug":"gemifloxacin-mesylate","phase":"marketed","mechanism":"Small molecule","indications":["Acute bacterial bronchitis","Acute exacerbation of chronic bronchitis","Bacterial pneumonia","Chlamydial pneumonia","Haemophilus influenzae pneumonia"],"catalyst":""},{"name":"Fang Le Shu (Follitrope)","genericName":"Fang Le Shu (Follitrope)","slug":"fang-le-shu-follitrope","phase":"marketed","mechanism":"Follitrope is a recombinant follicle-stimulating hormone (FSH) that stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Anovulation and ovulatory dysfunction in women seeking fertility treatment"],"catalyst":""},{"name":"Guo Na Fen (Gonal-F)","genericName":"Guo Na Fen (Gonal-F)","slug":"guo-na-fen-gonal-f","phase":"marketed","mechanism":"Gonal-F is a recombinant follicle-stimulating hormone (FSH) that stimulates the ovaries to produce multiple eggs for assisted reproductive procedures.","indications":["Infertility in women undergoing assisted reproductive technology (ART) procedures","Anovulation in women with polycystic ovary syndrome (PCOS)","Male infertility (hypogonadotropic hypogonadism)"],"catalyst":""},{"name":"LB54640","genericName":"LB54640","slug":"lb54640","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LC350189 200 mg","genericName":"LC350189 200 mg","slug":"lc350189-200-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LG00034053","genericName":"LG00034053","slug":"lg00034053","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Phase 1b: LB-LR1109 and Atezolizumab","genericName":"Phase 1b: LB-LR1109 and Atezolizumab","slug":"phase-1b-lb-lr1109-and-atezolizumab","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"nonsteroidal anti-inflammatory drug","genericName":"nonsteroidal anti-inflammatory drug","slug":"nonsteroidal-anti-inflammatory-drug","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5aV054S0djRFFrdjB3bml4RGhBbVd2OFBSdlBqRTZZZ2Z4LXFMQVdvYXd2OHgzLW5RQjhtMk01ZUxnYXZxcEVSMHdIUHlDVG92NjFfakZYU3k3UjZtOXdTSEl1UVhQQQ?oc=5","date":"2026-04-05","type":"deal","source":"thelec.net","summary":"LG Chem Signs Deal to Market Endometriosis Drug in Korea, Thailand - thelec.net","headline":"LG Chem Signs Deal to Market Endometriosis Drug in Korea, Thailand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBoY0dkam9qWWVfXzFQSFFLeDRXSENNa0g5enJ4SGNxRUhQdnJlbGV3NlN3MThDeXhGTngzY0szQ1dBYlE1VXJpSVpaZEY4aFJQTU0tNlMzMkRaTWR1RzB6ZzUxNVE5WHJpVDljSE530gFyQVVfeXFMTUtveFpGTU1kcG1tZGw2Sk1vUDlXMWlqM3R1emwzaHUxZXI4ckMzMnpJQ3B6MkFrNXlMRjFQSm1VVGlGRGJ6blFZWElrdmxmUG5VN1RoUG1YelpnZlRTb0ExMU03VW9BVTVQcUFweHRsdlBn?oc=5","date":"2026-04-03","type":"pipeline","source":"koreabiomed.com","summary":"LG Chem signs Korea, Thailand rights to Mochida’s endometriosis drug Dinagest - koreabiomed.com","headline":"LG Chem signs Korea, Thailand rights to Mochida’s endometriosis drug Dinagest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5mN3EtVVRwYnZBelFtT0s5TmVMS2pNMGZyZHZ5b3RYelVqdTkwcGxHc1lUTUJabmt0OWZ5Ri1TRmdOX0kxejdScFQ0QkxzaVNyU3NTaDNwMTVRY2JZVEd1R2UwYVNnQUZvM2wxVEdB0gFyQVVfeXFMUFd6emxCV2R3TlFVRE9vMXNMRHQ5ZjZwLWNGaXRwb0twdU13S29QMS1QdnktUDRNUEJodWZNLVdFSnQzSlBwVVhuUHRaX3dYVGo1OWRmTXNBZXdmT241NHh4RTZ6c29FbmJPM3VYbDExWnln?oc=5","date":"2026-03-23","type":"trial","source":"koreabiomed.com","summary":"LG Chem gout drug enters phase 3 trials in China - koreabiomed.com","headline":"LG Chem gout drug enters phase 3 trials in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9zVmtSZTVuVlRoaEwybDNJdFllV0lJS3hqTlFPOTNDcmJ0eXo4cktGeU1UNUVpQmFxZTlhc3JicUxqU0g1RTBvQ0dmNDNSYkxCVEM2Y2ZzZ9IBV0FVX3lxTE9zVmtSZTVuVlRoaEwybDNJdFllV0lJS3hqTlFPOTNDcmJ0eXo4cktGeU1UNUVpQmFxZTlhc3JicUxqU0g1RTBvQ0dmNDNSYkxCVEM2Y2ZzZw?oc=5","date":"2026-02-20","type":"trial","source":"aju press","summary":"LG Chem, GC Biopharma, Cho-A Pharma and Severance Hospital report trial, webinar, product and surgery milestones - aju press","headline":"LG Chem, GC Biopharma, Cho-A Pharma and Severance Hospital report trial, webinar, product and surgery milestones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOcUdCOUNDUzI1VlJOMGF2YmJJYW5jMjFYQlczenJRQVM3b0VTUTZvYXV2VE9FYTJSZkU2VUpsLUh1VHJST3JlVUNNOS1rbWJNRGxMYmxCSzM0QW1tblRSWk1ib3ktVzVjLWFNN2VxelBwX3pLbnBSWG45UnNjcmE5akJzYlQ5NDRFNlRjX3ZKazItOGV4RVZsc2ZIY3pOQ1ppLTV2UWZjRlBkdlRnOEgtODRvTThUYjVfV1FzaVdJTnFqOVdNdlU5Ykt4bXBfVjRhU2JMT1lzcnRGckFTYjhPODVfWTlOZ1dqd1NvM1UxWTk2Y2k2cnBmaWZYaE5KZWs?oc=5","date":"2026-01-14","type":"trial","source":"PR Newswire","summary":"AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab - PR Newswire","headline":"AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9Ra1c4UVAxNHczRkNXT0IwVU9UcU04dWJMMjdiN2Vjc2hNU2RpMHlLY2psTWltdnNONGJfN0QtdWtPbDZqV0l3R3NuNlA1OEQtYkxrbU1SZEdfakHSAVdBVV95cUxQbXJnYk8xNlhVVVJuUElzT2V3QTZyc1JRbENPc04wSVRUVGgyNTY5NTVWN25TWFZlaUE5Y1JreHpEeC1SMGNOY1h5SldmTnpHMnNGdHE3b3M?oc=5","date":"2025-11-27","type":"trial","source":"aju press","summary":"LG Chem replaces CEO, taps materials chief Kim Dong-chun to lead next phase - aju press","headline":"LG Chem replaces CEO, taps materials chief Kim Dong-chun to lead next phase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxObTJ2bUlDNllfbXFEUG5GRkNXaEhjaGJ2NURZVjlpQ0dmNEhVY1ZueVA4Z2E1MjBZOUd1Y0dWVkFFV0EyRHFLamxtdFROYkxBQVpNbUlJZXNqVV9aMmZJaExBQ2JldFFaeURlZVlENWFSYTVqRThZM1pxUXREYTNUNExOWkhSMHg1RHNHTDBYZ1pMQ2lzU3RQdUNkZTJWSFFZTV9sRXRfZ2FLblJYeGZ5UQ?oc=5","date":"2025-11-02","type":"pipeline","source":"Smartkarma","summary":"Last Week In Event SPACE: Nidec/Ibiden, LG Chem, Mayne Pharma, Jardine Matheson - Smartkarma","headline":"Last Week In Event SPACE: Nidec/Ibiden, LG Chem, Mayne Pharma, Jardine Matheson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8xbS1Ieko4c2RmUGx3bm9zaDl6d2ExR0t6X3FraDNfMGVyejhBV21RbHNXZVlTRUR5enl6aDhRTlJBNzl4ZmE3RGsyMFlvM2V4Y2ppU0hLYW5jOFQzZDdBRjN3Y1VFTHlrQjNYMkZ30gFyQVVfeXFMTUFITElJbEQxOS1YUXBkQ3ZoRnhCa09zV2pGNExXamkyaUk2S1hmd0ZXUTgzYnJiUXRDOGZCa2cyRVpzbk9rVFhfUWNOWUxYbktqN2hyd2toRFJFTTdEMUpDU3ZXRnVfSDlkMTF6QVozREJR?oc=5","date":"2025-08-07","type":"pipeline","source":"koreabiomed.com","summary":"LG Chem to sell aesthetics unit to PE firm for ₩200 billion - koreabiomed.com","headline":"LG Chem to sell aesthetics unit to PE firm for ₩200 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBqX2FDZEFTdjM1NWNQWk5Yd0hZOWRFSlZRZjVlT25zT3VrT3NwS3BJdm9iM29lbzN5Tzl4dVF0MkhvVGhIc3lyUzZrSjZrVjNuVHRWMHFCMkQ1c1A1SXhVN0pyXzlIanBGMVdCMDA1QlRETGZ0S3BIV1pZRQ?oc=5","date":"2025-02-09","type":"pipeline","source":"KED Global","summary":"LG Chem embarks on sale of dermal filler business worth $343 million - KED Global","headline":"LG Chem embarks on sale of dermal filler business worth $343 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9DMXk0SEFROENHNDdINUV2aTJ0VVQ5blV0QnFnTmhZZVFCMmphNmJCdkJjdUVWbE9HN1hXN1QzR2RxeGtBdnVhcnlIRnA3UzFiSDdPdQ?oc=5","date":"2024-07-03","type":"pipeline","source":"LG Corp","summary":"LG Chem Enters Chinese Osteoarthritis Treatment Market - LG Corp","headline":"LG Chem Enters Chinese Osteoarthritis Treatment Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQUpadzEwUW1NUUp1Y1hlQjJqVk80RjNESG9CN3laUnoyS3Q5X2otdlliYUV1dVFxcTA2SzEwVm9rMVlfTDQ1ai1IdTNiR0pPbnJ6SFg4OEJDb1Q4a25xTlVWZ09POE1JaG95RDJUZmZpTHR3b2dZTkZzRzdYT3ZEVGNNN0NxVW41V0lacmxSRzRBR0RuSzFTZnE0NkhFbmtRb1pKUnhhNTdab2M?oc=5","date":"2024-01-29","type":"pipeline","source":"Massachusetts Biotechnology Council","summary":"Inspiring Science & Leading Innovation: A Pharma Day Q&A with LG Chem - Massachusetts Biotechnology Council","headline":"Inspiring Science & Leading Innovation: A Pharma Day Q&A with LG Chem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPZE50ZEYzOXZSdkJDRHBmM1prcGtkVXN3ZUJZVXpGT3ZzbGQwM2c5SENsV2NmTV9iVkUycDlPUkRkLVliSkROaXJYdmRaaVViVFEteGdoY0ZaNkQ4dmlsRlpKZlVjeU1zelBRQlU5VjdNUWMtV0V2NkVlNzVBQW1kam9EN0FWSWpyZmFsV0VBZERxRVJG?oc=5","date":"2022-10-18","type":"pipeline","source":"Fierce Pharma","summary":"LG Chem picks up Aveo and its kidney cancer drug Fotivda for $566M - Fierce Pharma","headline":"LG Chem picks up Aveo and its kidney cancer drug Fotivda for $566M","sentiment":"neutral"}],"patents":[],"drugCount":13,"phaseCounts":{"phase_2":2,"marketed":6,"phase_3":1,"phase_1":4},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}